Blood-Borne and Sexual Transmission of Human Herpesvirus 8 in Women with or at Risk for Human Immunodeficiency Virus Infection
Michael J. Cannon, Ph.D., Sheila C. Dollard, Ph.D., Dawn K. Smith, M.D., Robert S. Klein, M.D., Paula Schuman, M.D., M.P.H., Josiah D. Rich, M.D., M.P.H., David Vlahov, Ph.D., Philip E. Pellett, Ph.D., for The HIV Epidemiology Research Study Group
Background Human herpesvirus 8 (HHV-8), the causal agent ofKaposi's sarcoma, is transmitted sexually among homosexual men,but little is known of its transmission among women. AlthoughHHV-8 has been detected in blood, there has been no clear evidenceof blood-borne transmission.
Methods We identified risk factors for HHV-8 infection in 1295women in Baltimore, Detroit, New York, and Providence, RhodeIsland, who reported high-risk sexual behavior or drug use.HHV-8 serologic studies were performed with two enzyme-linkedimmunosorbent assays.
Results In univariate analyses, HHV-8 was associated with blackrace, Hispanic ethnic background, a lower level of education,and infection with syphilis, the human immunodeficiency virus(HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV).The risk of seropositivity for HHV-8 increased with the frequencyof injection-drug use (P<0.001); HHV-8 seroprevalence amongthe women who used drugs daily was three times that among womenwho never injected drugs. Among the women with a low risk ofsexual transmission, HHV-8 seroprevalence was 0 percent in thosewho had never injected drugs and 36 percent in those who hadinjected drugs (P<0.001). However, injection-drug use waslinked less strongly to HHV-8 infection than to infection withHBV or HCV. In a multivariate analysis, independent predictorsof HHV-8 seropositivity included HIV infection (odds ratio,1.6; 95 percent confidence interval, 1.1 to 2.2), syphilis infection(odds ratio, 1.8; 95 percent confidence interval, 1.1 to 2.8),and daily injection-drug use (odds ratio, 3.2; 95 percent confidenceinterval, 1.4 to 7.6).
Conclusions Both injection-drug use and correlates of sexualactivity were risk factors for HHV-8 infection in the womenstudied. The independent association of HHV-8 infection withinjection-drug use suggests that HHV-8 is transmitted throughneedle sharing, albeit less efficiently than HBV, HCV, or HIV.
Source Information
From the Centers for Disease Control and Prevention, Atlanta (M.J.C., S.C.D., D.K.S., P.E.P.); Rollins School of Public Health, Emory University, Atlanta (M.J.C.); the Division of Infectious Diseases, Department of Medicine, and the Department of Epidemiology and Social Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, N.Y. (R.S.K.); the Division of Infectious Diseases, School of Medicine, Wayne State University, Detroit (P.S.); Brown University, Providence, R.I. (J.D.R.); and the Department of Epidemiology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, and the New York Academy of Medicine, New York (D.V.).
Address reprint requests to Dr. Pellett at the Centers for Disease Control and Prevention, 1600 Clifton Rd., Mailstop G18, Atlanta, GA 30333, or at ppellett{at}cdc.gov.
Minhas, V., Crabtree, K. L., Chao, A., M'soka, T. J., Kankasa, C., Bulterys, M., Mitchell, C. D., Wood, C.
(2008). Early Childhood Infection by Human Herpesvirus 8 in Zambia and the Role of Human Immunodeficiency Virus Type 1 Coinfection in a Highly Endemic Area. Am J Epidemiol
168: 311-320
[Abstract][Full Text]
Jaspan, D.
(2007). Erythropoietic therapy: Cost efficiency and reimbursement. Am J Health Syst Pharm
64: S19-S29
[Abstract][Full Text]
Laney, A. S., Peters, J. S., Manzi, S. M., Kingsley, L. A., Chang, Y., Moore, P. S.
(2006). Use of a Multiantigen Detection Algorithm for Diagnosis of Kaposi's Sarcoma-Associated Herpesvirus Infection.. J. Clin. Microbiol.
44: 3734-3741
[Abstract][Full Text]
Hladik, W., Dollard, S. C., Mermin, J., Fowlkes, A. L., Downing, R., Amin, M. M., Banage, F., Nzaro, E., Kataaha, P., Dondero, T. J., Pellett, P. E., Lackritz, E. M.
(2006). Transmission of Human Herpesvirus 8 by Blood Transfusion.. NEJM
355: 1331-1338
[Abstract][Full Text]
Casper, C., Meier, A. S., Wald, A., Morrow, R. A., Corey, L., Moscicki, A.-B.
(2006). Human Herpesvirus 8 Infection Among Adolescents in the REACH Cohort.. Arch Pediatr Adolesc Med
160: 937-942
[Abstract][Full Text]
Teo, C.G.
(2006). Conceptual Emergence of Human Herpesvirus 8 (Kaposi's Sarcoma-associated Herpesvirus) as an Oral Herpesvirus. ADR
19: 85-90
[Abstract][Full Text]
Brown, E. E, Whitby, D., Vitale, F., Fei, P. C., Del Carpio, C., Marshall, V., Alberg, A. J, Serraino, D., Messina, A., Gafa, L., Goedert, J. J, The Classical Kaposi Sarcoma Working Group,
(2005). Correlates of Human Herpesvirus-8 DNA detection among adults in Italy without Kaposi sarcoma. Int J Epidemiol
34: 1110-1117
[Abstract][Full Text]
Gentile, G., Capobianchi, A., Volpi, A., Palu, G., Pica, F., Calistri, A., Biasolo, M. A., Martino, P.
(2005). Human Herpesvirus 8 DNA in Serum During Seroconversion in Allogeneic Bone Marrow Transplant Recipients. JNCI J Natl Cancer Inst
97: 1008-1011
[Abstract][Full Text]
Laney, A. S., De Marco, T., Peters, J. S., Malloy, M., Teehankee, C., Moore, P. S., Chang, Y.
(2005). Kaposi Sarcoma-Associated Herpesvirus and Primary and Secondary Pulmonary Hypertension. Chest
127: 762-767
[Abstract][Full Text]
Plancoulaine, S., Abel, L., Tregouet, D., Duprez, R., van Beveren, M., Tortevoye, P., Froment, A., Gessain, A.
(2004). Respective Roles of Serological Status and Blood Specific Antihuman Herpesvirus 8 Antibody Levels in Human Herpesvirus 8 Intrafamilial Transmission in a Highly Endemic Area. Cancer Res.
64: 8782-8787
[Abstract][Full Text]
Gandhi, M., Koelle, D.M., Ameli, N., Bacchetti, P., Greenspan, J.S., Navazesh, M., Anastos, K., Greenblatt, R.M.
(2004). Prevalence of Human Herpesvirus-8 Salivary Shedding in HIV Increases with CD4 Count. JDR
83: 639-643
[Abstract][Full Text]
Sergerie, Y., Abed, Y., Roy, J., Boivin, G.
(2004). Comparative Evaluation of Three Serological Methods for Detection of Human Herpesvirus 8-Specific Antibodies in Canadian Allogeneic Stem Cell Transplant Recipients. J. Clin. Microbiol.
42: 2663-2667
[Abstract][Full Text]
Mbulaiteye, S. M., Biggar, R. J., Bakaki, P. M., Pfeiffer, R. M., Whitby, D., Owor, A. M., Katongole-Mbidde, E., Goedert, J. J., Ndugwa, C. M., Engels, E. A.
(2003). Human Herpesvirus 8 Infection and Transfusion History in Children With Sickle-Cell Disease in Uganda. JNCI J Natl Cancer Inst
95: 1330-1335
[Abstract][Full Text]
Dourmishev, L. A., Dourmishev, A. L., Palmeri, D., Schwartz, R. A., Lukac, D. M.
(2003). Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis. Microbiol. Mol. Biol. Rev.
67: 175-212
[Abstract][Full Text]
Busch, M. P., Kleinman, S. H., Nemo, G. J.
(2003). Current and Emerging Infectious Risks of Blood Transfusions. JAMA
289: 959-962
[Full Text]
Masur, P. b. H., Kaplan, J. E., Holmes, K. K.
(2002). Guidelines for Preventing Opportunistic Infections among HIV-Infected Persons--2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. ANN INTERN MED
137: 435-478
[Abstract][Full Text]
Sarid, R., Klepfish, A., Schattner, A.
(2002). Virology, Pathogenetic Mechanisms, and Associated Diseases of Kaposi Sarcoma-Associated Herpesvirus (Human Herpesvirus 8). Mayo Clin Proc.
77: 941-949
[Abstract]
Ablashi, D. V., Chatlynne, L. G., Whitman, J. E. Jr., Cesarman, E.
(2002). Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, Diseases. Clin. Microbiol. Rev.
15: 439-464
[Abstract][Full Text]
O'Brien, T. R., Engels, E. A., Rosenberg, P. S., Goedert, J. J., Cannon, M. J., Pellett, P. E., Haverkos, H. W., Kopstein, A. N., Osmond, D. H., Martin, J. N.
(2002). Relationship Between Kaposi Sarcoma-Associated Herpesvirus and HIV. JAMA
287: 1525-1528
[Full Text]
Corchero, J. L., Mar, E.-C., Spira, T. J., Pellett, P. E., Inoue, N.
(2001). Comparison of Serologic Assays for Detection of Antibodies against Human Herpesvirus 8. CVI
8: 913-921
[Abstract][Full Text]
Previous
